Get the Weekly Intelligence Brief — top committee picks every Sunday.

BFLY vs SNY

Butterfly Network, Inc. vs Sanofi — AI-powered side-by-side comparison
BFLY
Butterfly Network, Inc.
67
Buy
VS
SNY
Sanofi
62
Insufficient Data
MetricBFLYSNY
AI Score 67 62
Price $9.36 $43.56
P/E Ratio -32.38× 23.06×
ROE -39.3% 10.9%
Revenue Growth YoY
Gross Margin 51.1% 72.8%
Debt / Equity 0.10× 0.34×
Dividend Yield 0.0% 5.5%
RSI (14) 66.4 53.1
Beta 2.084 0.278
Expected Upside

AI Committee View

Current Innellis committee reasoning for BFLY versus SNY.
BFLY leads by 5 points.

BFLY scores 67/100 (Buy) versus SNY at 62/100 (Insufficient Data).

BFLY Committee View
67% agreement
6 analysts

The primary driver is revenue growing 28.1% yoy -- genuine top-line momentum. The main limiting factor is roe of only -38.4% -- cheap may mean cheap for a reason. The committee is constructive but not yet at full conviction.

Bull Case
  • Revenue growing 28.1% YoY -- genuine top-line momentum — Growth
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
Bear Case
  • ROE of only -38.4% -- cheap may mean cheap for a reason — Value
  • Bollinger bandwidth of 52.6% signals elevated volatility — Risk
SNY Committee View
67% agreement
3 analysts

Some positive signals exist — vix regime is low -- calm backdrop supports risk-taking — but they are not yet strong enough to justify a Buy. The committee is monitoring for confirmation.

Bull Case
  • Weekly trend (downtrend) confirms the daily trend -- multi-timeframe agreement — Technical
  • VIX regime is low -- calm backdrop supports risk-taking — Macro
  • Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
  • Price structure making lower highs and lower lows — Technical
  • MACD histogram negative -- bearish momentum — Technical
  • Trend and market structure agree -- coherent bearish picture — Technical
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
BFLY Full Analysis SNY Full Analysis